[Disorders of cell membrane function in essential hypertension].
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D017301:Ca(2+) Mg(2+)-ATPase / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D002462:Cell Membrane / Q000032:analysis / Q000502:physiology*; D002463:Cell Membrane Permeability; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D008054:Lipid Peroxides / Q000096:biosynthesis; D008563:Membrane Lipids / Q000378:metabolism; D008565:Membrane Proteins / Q000032:analysis; D011188:Potassium / Q000378:metabolism; D011379:Prognosis; D051381:Rats; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000503:physiopathology
D000975:Antioxidants; D008054:Lipid Peroxides; D008563:Membrane Lipids; D008565:Membrane Proteins; D012964:Sodium; D000242:Cyclic AMP; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D000254:Sodium-Potassium-Exchanging ATPase; D006152:Cyclic GMP; D011188:Potassium; D002118:Calcium
Narusheniia funktsii kletochnykh membran pri gipertonicheskoĭ bolezni.